.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Cantor Fitzgerald
Federal Trade Commission
US Army
Accenture
Novartis
Chubb
McKesson
Harvard Business School
Fuji

Generated: December 12, 2017

DrugPatentWatch Database Preview

Vorinostat - Generic Drug Details

« Back to Dashboard

What are the generic sources for vorinostat and what is the scope of vorinostat freedom to operate?

Vorinostat
is the generic ingredient in one branded drug marketed by Merck and is included in one NDA. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Vorinostat has one hundred and thirty-two patent family members in thirty-five countries.

There are two drug master file entries for vorinostat. One supplier is listed for this compound.

Pharmacology for vorinostat

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
MerckZOLINZAvorinostatCAPSULE;ORAL021991-001Oct 6, 2006RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
MerckZOLINZAvorinostatCAPSULE;ORAL021991-001Oct 6, 2006RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
MerckZOLINZAvorinostatCAPSULE;ORAL021991-001Oct 6, 2006RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
MerckZOLINZAvorinostatCAPSULE;ORAL021991-001Oct 6, 2006RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
MerckZOLINZAvorinostatCAPSULE;ORAL021991-001Oct 6, 2006RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
MerckZOLINZAvorinostatCAPSULE;ORAL021991-001Oct 6, 2006RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
MerckZOLINZAvorinostatCAPSULE;ORAL021991-001Oct 6, 2006RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
MerckZOLINZAvorinostatCAPSULE;ORAL021991-001Oct 6, 2006RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
MerckZOLINZAvorinostatCAPSULE;ORAL021991-001Oct 6, 2006RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: vorinostat

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
MerckZOLINZAvorinostatCAPSULE;ORAL021991-001Oct 6, 2006► Subscribe► Subscribe
MerckZOLINZAvorinostatCAPSULE;ORAL021991-001Oct 6, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: vorinostat

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,148,257Methods of treating mesothelioma with suberoylanilide hydroxamic acid► Subscribe
8,288,440Formulations of suberoylanilide hydroxamic acid and methods for producing same► Subscribe
7,847,122Polymorphs of suberoylanilide hydroxamic acid► Subscribe
7,375,137Methods of treating cancer with HDAC inhibitors► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: vorinostat

Country Document Number Estimated Expiration
Poland379887► Subscribe
New Zealand553204► Subscribe
TaiwanI365068► Subscribe
Ukraine83065► Subscribe
Russian Federation2354362► Subscribe
Canada2671976► Subscribe
Nicaragua200700031► Subscribe
South Korea100924737► Subscribe
Hong Kong1072362► Subscribe
Australia2006249440► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Chinese Patent Office
Covington
Novartis
Federal Trade Commission
Argus Health
Queensland Health
Farmers Insurance
Deloitte
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot